Please login to the form below

clinical data

This page shows the latest clinical data news and features for those working in and with pharma, biotech and healthcare.

Roche’s first TIGIT data points to benefit when added to Tecentriq

There had been high expectations for the first clinical data from Roche’s TIGIT-targeting antibody tiragolumab, developed as a companion drug to Tecentriq, and the results didn’t wholly disappoint. ... Overall, however, the picture is positive, with

Latest news

Novartis says data backs safety of on-hold intrathecal Zolgensma

Data also demonstrated 'remarkable' efficacy in SMA type 2. Novartis has reported phase 1/2 trial results with its intrathecal formulation of gene therapy Zolgensma, placed under a clinical hold by ... AveXis says it provided data showing it received no
FDA maintains COVID-19 therapeutics must meet a ‘gold standard’

The agency said it would do this by “relying on data from adequate and well-controlled trials to most efficiently determine if an experimental treatment can safely and effectively benefit patients”. ... Speaking on the development of choloroquine for
Shionogi launches thrombocytopenia treatment Mulpleo in the UK

The positive recommendations of the drug were based on the data from two phase 3 clinical trials – L-PLUS 1 and L-PLUS 2.
Trevena gets second go at FDA approval for pain drug

Some concluded there wasn’t enough data on side effects like respiratory depression compared to equivalent doses of current opioids such as morphine – even though oliceridine was specifically developed to reduce ... The FDA agreed with that assessment
Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Despite submitting only the PFS data – the more robust overall survival data was not yet available – the committee were ultimately satisfied with the risk-benefit profile of Cymraza. ... the clinical meaningfulness of the data from the RELAY trial,

More from news
Approximately 0 fully matching, plus 796 partially matching documents found.

Latest Intelligence

After the watershed: the dos and don’ts of digital KPIs in a post-pandemic world

Clinical behaviour change is very difficult to prove, not just digitally but across any channel. ... they may have downloaded clinical data for review or requested further information; or they may have returned to look again at useful material, or
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

It now has more than 300 CAR-T clinical trials underway and collaboration with European and US-based multinationals is now commonplace. ... Novartis has the knowledge and expertise to set the standard for this new therapy platform to support excellent
Staying ahead in the era of precision medicine

At. the same time, we are seeing companies like Flatiron Health using real-world data to learn from patients who are not in clinical trials. ... Finally, patient privacy and ethical considerations become more acute as greater volumes of personal genetic
Alzheimer’s: the search for a cure

Even so, the clinical data package is imperfect, at best. A more sceptical reading of the package is that it lacks even one successful trial, given that the failed futility analysis ... The preponderance of the data indicates aducanumab doesn’t provide
20 for 2020 – Five pharma companies to watch

BMS has warned its drug will be under pressure next year, but says it has a plan to fight back – predicated on new clinical data and regulatory decisions in 2020.

More from intelligence
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest appointments

Orchard Therapeutics appoints Mark Rothera as CEO

He joins from PTC Therapeutics. London, UK-based Orchard Therapeutics has appointed Mark Rothera as its new president and chief executive officer at a time when the group progresses its clinical ... The clinical data we’ve seen to date with Orchard’s
Clinerion appoints new regional head

Bariş Erdoğan takes up new role at the clinical trial data firm. ... Swiss-based clinical trial data firm Clinerion has appointed Bariş Erdoğan as its new regional head in a role that focuses on the expansion of its activities in Eastern Europe, the
Novocure’s chief commercial officer to step down

clinical data in Q4 2014.
J&J’s clinical research neuroscience director joins MedAvante

Dr Michael Ropacki becomes head of R&D at the clinical data service. ... Global clinical data services company MedAvante has appointed Dr Michael Ropacki as vice president of research and development.
Quanticate names chief operating officer

Alan Morgan joins the data-focused clinical research organisation. London-based clinical research organisation Quanticate has appointed Alan Morgan as its chief operating officer. ... As the clinical data experts, Alan's leadership over our operational

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

EPG Health

Group Director Scientific Communications. "EPG Health did a fantastic job of re-purposing our clinical trial data into a digital format that was exciting and engaging for our key target audience. ... Astellas. "The extent to which we have increased
COUCH Health demands the clinical research industry improves participant diversity

Lack of diversity and inclusion is one of the clinical research industry’s biggest issues failing to be effectively addressed. ... We all have a duty to create meaningful engagement with diverse groups that improves the data that’s generated from
Nurses on the frontline – World Health Day 2020

data for clinical studies.
The field team are off the road! What should they do next?

Then, it is up to your team to communicate complex data and messages succinctly and memorably. ... STAYING UP TO DATE WITH THE DATA AND CLINICAL LANDSCAPE. With many field-based roles at a temporary standstill, the teams have a rare chance to focus on
Mapping the clinical and emotional journey to better understand lived experience

A clinical pathway can be produced by analysing Hospital Episode Statistics (HES) data: a records-based system that covers all NHS Trusts in England. ... All data collected is pseudonymised and follows patients’ clinical touch points during their time